Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Javier Santesmases

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Medicina Clinica|November 28, 2019
Adverse drug reactionsEva Montané, Javier Santesmases
Frontiers in Pharmacology|February 16, 2023
Characteristics of drug safety alerts issued by the Spanish Medicines AgencyEva Montané, Javier Santesmases
Drug and Alcohol Dependence|June 14, 2006
Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001Roberto Muga, Arantza Sanvisens, Ferran Bolao, et al.
Revista Espanola De Cardiologia (English Ed.)|June 20, 2016
Hemoglobin Kinetics and Long-term Prognosis in Heart FailureCarles Díez-López, Josep Lupón, Marta de Antonio, et al.
Mayo Clinic Proceedings|June 6, 2015
Aging and Heart Rate in Heart Failure: Clinical Implications for Long-term MortalityJosep Lupón, Mar Domingo, Marta de Antonio, et al.
International Journal of Cardiology|February 9, 2018
Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fractionPedro Moliner, Josep Lupón, Jaume Barallat, et al.
Revista Espanola De Cardiologia (English Ed.)|February 21, 2017
Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart FailureCristina Pacho, Mar Domingo, Raquel Núñez, et al.
European Journal of Heart Failure|April 8, 2017
Recovered heart failure with reduced ejection fraction and outcomes: a prospective studyJosep Lupón, Carles Díez-López, Marta de Antonio, et al.
Journal of the American Heart Association|March 26, 2016
Weight Loss in Obese Patients With Heart FailureElisabet Zamora, Carles Díez-López, Josep Lupón, et al.
Plos One|May 14, 2021
Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?Josep Lupón, Evelyn Santiago-Vacas, Germán Cediel, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Medicina Clinica|November 28, 2019
Adverse drug reactionsEva Montané, Javier Santesmases
Frontiers in Pharmacology|February 16, 2023
Characteristics of drug safety alerts issued by the Spanish Medicines AgencyEva Montané, Javier Santesmases
Drug and Alcohol Dependence|June 14, 2006
Significant reductions of HIV prevalence but not of hepatitis C virus infections in injection drug users from metropolitan Barcelona: 1987-2001Roberto Muga, Arantza Sanvisens, Ferran Bolao, et al.
Revista Espanola De Cardiologia (English Ed.)|June 20, 2016
Hemoglobin Kinetics and Long-term Prognosis in Heart FailureCarles Díez-López, Josep Lupón, Marta de Antonio, et al.
Mayo Clinic Proceedings|June 6, 2015
Aging and Heart Rate in Heart Failure: Clinical Implications for Long-term MortalityJosep Lupón, Mar Domingo, Marta de Antonio, et al.
International Journal of Cardiology|February 9, 2018
Bio-profiling and bio-prognostication of chronic heart failure with mid-range ejection fractionPedro Moliner, Josep Lupón, Jaume Barallat, et al.
Revista Espanola De Cardiologia (English Ed.)|February 21, 2017
Early Postdischarge STOP-HF-Clinic Reduces 30-day Readmissions in Old and Frail Patients With Heart FailureCristina Pacho, Mar Domingo, Raquel Núñez, et al.
European Journal of Heart Failure|April 8, 2017
Recovered heart failure with reduced ejection fraction and outcomes: a prospective studyJosep Lupón, Carles Díez-López, Marta de Antonio, et al.
Journal of the American Heart Association|March 26, 2016
Weight Loss in Obese Patients With Heart FailureElisabet Zamora, Carles Díez-López, Josep Lupón, et al.
Plos One|May 14, 2021
Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?Josep Lupón, Evelyn Santiago-Vacas, Germán Cediel, et al.
Pageof 3